Position in KURA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,798,396
+$1,759,517 QoQ
Shares Held
221,205
+5811.4% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Derivatives in KURA
reported options exposure · as of Mar 31, 2026CallValue
$243,900
CallShares
30,000
PutValue
$55,284
PutShares
6,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in KURA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,798,396 | 221,205 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $243,900 | 30,000 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $55,284 | 6,800 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $119,485 | 11,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $38,879 | 3,742 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $110,134 | 10,600 | Put | Sole | 2026-02-13 | |
| 2025-06-30 | $2,390,637 | 414,322 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,332,056 | 504,857 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,671,329 | 536,318 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $166,090 | 8,500 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $212,986 | 10,900 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $11,164,472 | 571,365 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $232,667 | 11,300 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $249,139 | 12,100 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $1,545,917 | 75,081 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,775,765 | 83,252 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $23,463 | 1,100 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $654,893 | 45,542 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,415,824 | 264,893 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $874,669 | 82,672 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $3,661,890 | 268,074 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $437,641 | 20,990 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||